Showing results (21-30 of 349) with videos related to
Sort By:
Pageof 35
Biological Psychiatry|December 22, 1999
The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disordersC Heim, C B NemeroffThe Journal of Clinical Psychiatry|September 1, 1994
The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous systemB Kinkead, C B NemeroffThe Journal of Clinical Psychiatry|July 23, 1998
Lithium augmentation of antidepressants in treatment-refractory depressionS Heit, C B NemeroffProgress in Clinical and Biological Research|January 1, 1985
Do neuropeptide systems mediate some of the effects of antipsychotic drugs?G Bissette, C B NemeroffRegulatory Peptides|October 29, 1991
The neurobiology of neurotensin: focus on neurotensin-dopamine interactionsJ Kasckow, C B NemeroffCNS & Neurological Disorders Drug Targets|April 14, 2006
Novel treatments of schizophrenia: targeting the neurotensin systemB Kinkead, C B NemeroffProgress in Clinical and Biological Research|January 1, 1985
Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studiesC B Nemeroff, G BissetteBiological Psychiatry|June 30, 2001
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studiesC Heim, C B NemeroffThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802B Levant, C B NemeroffThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudateB Levant, C B NemeroffPageof 35